SGVG CHITOSAN 350MG CAPSULE
SGVG CHITOSAN 350MG CAPSULE : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
- Registration number
- MAL20000420X
- Type
- Health supplement
- Published status
- PRODUCT APPROVED
- Licence holder
- WHITE HERON PHARMACEUTICAL SDN. BHD.
- Manufacturer
- WHITE HERON PHARMACEUTICAL SDN. BHD.
- Registration period starting
- 2025-04-09
- Published validity end
- 2030-04-09
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
No point flagged by the rules applied to recognised ingredients.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| CHITOSAN | CHITOSAN[350MG] | Chitosan |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Active ingredients
- CHITOSAN[350MG]
- Valid until
- 2030-04-09
- Registration date
- 2025-04-09
- Published description
- HEALTH SUPPLEMENT
- Licence holder
- WHITE HERON PHARMACEUTICAL SDN. BHD.
- Producer
- WHITE HERON PHARMACEUTICAL SDN. BHD.
- Published name
- SGVG CHITOSAN 350MG CAPSULE
- Published reference
- 1999113746X
- Registration number
- MAL20000420X
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL20000420X
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- CHITOSAN
Read the warning, when it applies and the studies cited
CHITOSAN
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Pittler et al. 1999).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: All products (except for weight management).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Condition of application: Weight management.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.
Contraindications
Condition of application: All products.
Do not use if you have an allergy to seafood.
Condition of application: Weight management.
Do not use if you are pregnant (HC 2010).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
When using this product you may experience gastrointestinal discomfort/disturbances (Moraru et al. 2018; Mhurchu et al. 2004; Pittler et al. 1999).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.